Litcius/Paper detail

The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K

Mikołaj Słabicki, Zuzanna Kozicka, Georg Petzold, Yen-Der Li, Manisha Manojkumar, R.D. Bunker, Katherine A. Donovan, Quinlan Sievers, Jonas Koeppel, Dakota J. Suchyta, Adam S. Sperling, Emma C. Fink, Jessica A. Gasser, Li R. Wang, Steven M. Corsello, Rob S. Sellar, Max Jan, Dennis Gillingham, Claudia Scholl, Stefan Fröhling, Todd R. Golub, Eric S. Fischer, Nicolas H. Thomä, Benjamin L. Ebert

2020Nature408 citationsDOIOpen Access PDF

Topics & Concepts

Cyclin-dependent kinaseCDK inhibitorGLUECyclinChemistryCancer researchBiologyBiochemistryMaterials scienceCell cycleCellComposite materialProtein Degradation and InhibitorsUbiquitin and proteasome pathwaysCancer-related Molecular Pathways
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K | Litcius